Explore how Tolvaptan, a V2 receptor antagonist, is revolutionizing ADPKD treatment by slowing kidney function decline. Learn about its mechanism, benefits, and impact on patient outcomes from NINGBO INNO PHARMCHEM CO.,LTD.
